COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

Clinical trial NCT05020145 · COMPLETED

Trial details

NCT number: NCT05020145
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Immunocompromised Immunosuppressed Covid-19 SARS-COV-2 SARS-COV-2 Infection Breakthrough Infection

Start date: 2021-08-25
Primary completion: 2021-12-17
Enrollment: 1277747

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.